All In Biotech

Free tool

FAERS Monitor: Krintafel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210795 or its brand name (Krintafel, Tafenoquine Succinate). Reports on generic versions are filed under their own applications.

Reports

11

Serious

7

64% of reports

Hospitalization

5

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3
  • off label use3
  • bacteraemia2
  • blood fibrinogen decreased2
  • blood lactate dehydrogenase increased2
  • blood triglycerides increased2
  • candida infection2
  • drug effective for unapproved indication2
  • haemolysis2
  • haemolytic anaemia2
  • haemophagocytic lymphohistiocytosis2
  • infection2
  • lactic acidosis2
  • leukoerythroblastosis2
  • malaria2

Reports by year received

View as table
YearReports
20192
20201
20224
20232
20241
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,148 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
leukoerythroblastosis239061.510978.943,063
malaria25445.31551.16,106
blood fibrinogen decreased23357.9957.33,768
haemophagocytic lymphohistiocytosis2509.7145.5570
haemolysis2495.3141.4554
haemolytic anaemia2426.9121.9477
bacteraemia2322.492.0360
blood lactate dehydrogenase increased2241.368.9269
candida infection2226.564.6252
blood triglycerides increased2216.561.8241
drug effective for unapproved indication2130.637.3144
lactic acidosis2118.133.7130
infection226.47.527
off label useSignal36.62.510
drug ineffectiveSignal34.41.75

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.